Grace Wade
Grace Wade is a health reporter based in the United States who covers public health, nutrition, and biotechnology for New Scientist. She has a strong educational background in journalism and science from Northwestern University's Medill School of Journalism. Prior to joining New Scientist, Grace worked as an associate features editor for Health magazine and an associate health editor for Insider. She has also contributed to Popular Science, covering topics such as wildlife, the environment, and health. In her free time, Grace enjoys landscape and concert photography.
84%
The Daily's Verdict
This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.
Bias
94%
Examples:
- Grace Wade appears to be a fair and balanced reporter, with no instances of promoting personal opinions or political agendas in her articles.
- She presents factual information without distortion or misrepresentation.
Conflicts of Interest
90%
Examples:
- There are no clear instances of conflicts of interest in Grace's reporting.
Contradictions
86%
Examples:
- However, this is the only instance of contradictory information in her articles.
- In one article, Grace reports contradictory information about niacin supplements and their effects on heart health. She mentions that niacin supplements are linked to a greater risk of heart attacks and strokes, which contradicts the common belief that niacin is beneficial for cardiovascular health.
Deceptions
65%
Examples:
- Grace Wade uses misleading language in some of her articles, but these instances do not constitute deceptive practices.
- However, these instances are few and far between, and they do not significantly impact the overall quality of her reporting.
- She occasionally presents information that could be interpreted as implying causation between variables when no such evidence exists.
Recent Articles
New Study Suggests Semaglutide's Role in Smoking Cessation: Reducing Tobacco Cravings with Diabetes Medication
Broke On: Tuesday, 30 July 2024New study suggests semaglutide-based medicines like Ozempic and Wegovy may aid in smoking cessation by reducing tobacco cravings. Researchers at Case Western Reserve University found that individuals using semaglutide were less likely to seek tobacco-related healthcare than those on other diabetes medications, indicating its potential for addiction treatment. The drug's effect on the reward system in the brain may contribute to this ability. Blocking Inflammatory Protein IL-11 Extends Healthy Lifespan of Mice by 25%: New Study Reveals
Broke On: Wednesday, 17 July 2024Scientists discovered that blocking the inflammatory protein IL-11 extends healthy lifespan of mice by 25%, reducing deaths from cancer and improving muscle strength. Studies conducted by MRC Laboratory of Medical Science, Imperial College London, and Duke-NUS Medical School revealed IL-11's pro-inflammatory role in aging. Anti-IL-11 treatments are currently in human clinical trials for age-related diseases. ADHD Diagnoses on the Rise in the US: Factors and Trends
Broke On: Thursday, 23 May 2024One in nine children in the US, approximately 7.1 million, were diagnosed with ADHD in 2022 according to recent data. Factors contributing to the rise include increased awareness and understanding of the condition and more available treatments. Children from lower income and education households, as well as those living in rural or suburban areas, have a higher prevalence of diagnosed ADHD. Hispanic children and those from non-English speaking households are less likely to take ADHD medication than others. Midwestern and Southern children are more likely to be taking medication. New Study Links High Niacin Levels to Increased Heart Disease Risk through Inflammation and Blood Vessel Damage
Broke On: Monday, 19 February 2024A new study published in Nature Medicine has found that high levels of niacin, an essential B vitamin commonly added to cereals and breads as a fortificant, may increase the risk of heart disease by triggering inflammation and damaging blood vessels. The metabolic product of excess niacin, 4PY, is linked to an increased risk of major cardiovascular events such as heart attack and stroke.